RAC 1.11% $1.83 race oncology ltd

Race Oncology announced encouraging outcomes from its joint...

  1. 78 Posts.
    lightbulb Created with Sketch. 5
    Race Oncology announced encouraging outcomes from its joint preclinical melanoma research program with the University of Newcastle. The Company also stated that the results proved Zantrene’s efficacy at killing high-Fat Mass and Obesity-associated protein (FTO) producing melanoma cell subtypes of different ranges. Backed by this announcement, the stock RAC rose over 4% to trade at AU$3.520 per share on ASX during the trading session which is a good news for investors investing in this stock.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.